These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 12355106)

  • 41. At ground level.
    Bertschinger J
    Nat Biotechnol; 2010 Aug; 28(8):775-7. PubMed ID: 20722095
    [No Abstract]   [Full Text] [Related]  

  • 42. Convincing a venture capitalist to invest in your idea.
    Dooley JF; Dooley JF
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980
    [No Abstract]   [Full Text] [Related]  

  • 43. Public biotech 2007--the numbers.
    Lawrence S; Lähteenmäki R
    Nat Biotechnol; 2008 Jul; 26(7):753-62. PubMed ID: 18612294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Merlin's maestro.
    Fletcher L
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE13-4. PubMed ID: 12089571
    [No Abstract]   [Full Text] [Related]  

  • 45. Little science, big bucks.
    DeFrancesco L
    Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
    [No Abstract]   [Full Text] [Related]  

  • 46. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

  • 47. Getting reimbursement for your product in the United States.
    Gold M
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE42-4. PubMed ID: 12874979
    [No Abstract]   [Full Text] [Related]  

  • 48. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 49. Rainbow biotech--South Africa's emerging sector.
    Louët S
    Nat Biotechnol; 2006 Nov; 24(11):1313-6. PubMed ID: 17093464
    [No Abstract]   [Full Text] [Related]  

  • 50. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
    Kewell B; Webster A
    Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
    [No Abstract]   [Full Text] [Related]  

  • 51. The evolution of the biotechnology industry in Germany.
    Müller C
    Trends Biotechnol; 2002 Jul; 20(7):287-90. PubMed ID: 12062972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Superscience me!
    Nat Biotechnol; 2007 Jun; 25(6):604. PubMed ID: 17557082
    [No Abstract]   [Full Text] [Related]  

  • 53. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs.
    Rinaldi A
    EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intellectual property as a foundation for funding.
    Meltzer SL; Marks MS; McCormick JT
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE47-50. PubMed ID: 12089588
    [No Abstract]   [Full Text] [Related]  

  • 55. Calling for entrepreneurs: London.
    Smaglik P
    Nat Biotechnol; 2002 Dec; 20(12):1281-2. PubMed ID: 12454679
    [No Abstract]   [Full Text] [Related]  

  • 56. Public biotechnology 2001--the numbers.
    Lähteenmäki R; Fletcher L
    Nat Biotechnol; 2002 Jun; 20(6):551-5. PubMed ID: 12042853
    [No Abstract]   [Full Text] [Related]  

  • 57. Russia becomes attractive as a source of IP for biotechs.
    Katsnelson A
    Nat Biotechnol; 2004 Sep; 22(9):1060. PubMed ID: 15340454
    [No Abstract]   [Full Text] [Related]  

  • 58. Start me up….
    Becker H
    Lab Chip; 2010 Dec; 10(23):3197-200. PubMed ID: 20976363
    [No Abstract]   [Full Text] [Related]  

  • 59. Rational financing.
    Birndorf HC
    Nat Biotechnol; 1999 Feb; 17 Suppl():BE33-4. PubMed ID: 10052325
    [No Abstract]   [Full Text] [Related]  

  • 60. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector.
    Senker J; Enzing C; Joly PB; Reiss T
    Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.